Grail Inc (GRAL)

$48.39 -0.99 (-2.00%)
Market Cap 1.74B
Revenue (ttm) 125.60M
Net Income (ttm) -2.03B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,613.86%
Debt to Equity Ratio 0.00
Volume 5,793,200
Avg Vol 1,504,274
Day's Range N/A - N/A
Shares Out 35.97M
Stochastic %K 76%
Beta N/A
Analysts Sell
Price Target $40.50

Company Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing,...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 833 694 2553
Website: grail.com
Address:
1525 O’Brien Drive, Menlo Park, United States
healthcareguru
healthcareguru Jun. 28 at 2:27 AM
PSA: LOOKING FOR NEW GREAT HEALTHCARE IDEAS (where maybe we overlooked / missed an opportunity)! DM me if you want to pitch an idea. #teamguru 💵🐺💪 $XLV $TDOC $HIMS $TEM $GRAL
0 · Reply
dubale
dubale Jun. 27 at 8:42 PM
$GRAL Anyone catching the volume spike last 15 minutes? Around 5 millions. Any idea?
2 · Reply
SHELBY_TRADING
SHELBY_TRADING Jun. 27 at 7:58 PM
$GRAL Fishes try to fud here. 😂😂😂 100$+ thats the plan !
0 · Reply
dubale
dubale Jun. 27 at 5:20 PM
$GRAL I don’t understand people who is selling at this level. If you short term trader you’re okay with that. But if you long term keep buying. It’s not double top trend. Stock will continue rise next week. Be smart!
1 · Reply
Bazzzigar
Bazzzigar Jun. 27 at 4:35 PM
$GRAL offering?
1 · Reply
dubale
dubale Jun. 27 at 3:40 PM
$GRAL Good time to take profit. Always buy on a down day!
0 · Reply
dubale
dubale Jun. 27 at 3:24 PM
$GRAL Perfecto!
1 · Reply
dubale
dubale Jun. 27 at 2:01 PM
$GRAL Remember $49+ level is resistance which could turn to support. Highly important level!
1 · Reply
Titoscoisas
Titoscoisas Jun. 26 at 11:50 PM
$GRAL
0 · Reply
rxptgh
rxptgh Jun. 26 at 11:10 PM
$GRAL a beast
0 · Reply
Latest News on GRAL
The Holy Grail of Automation: Now a Robot Can Unload a Truck

Jun 23, 2025, 5:30 AM EDT - 6 days ago

The Holy Grail of Automation: Now a Robot Can Unload a Truck

Grail Shares Jump on Promising Results for Galleri Study

Jun 18, 2025, 12:43 PM EDT - 10 days ago

Grail Shares Jump on Promising Results for Galleri Study

GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study

Jun 18, 2025, 9:01 AM EDT - 10 days ago

GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

May 30, 2025, 4:05 PM EDT - 4 weeks ago

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL to Present at Jefferies Global Healthcare Conference 2025

May 21, 2025, 4:05 PM EDT - 5 weeks ago

GRAIL to Present at Jefferies Global Healthcare Conference 2025

Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

May 14, 2025, 8:13 AM EDT - 6 weeks ago

Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

ALC

GRAIL, Inc. (GRAL) Q1 2025 Earnings Call Transcript

May 13, 2025, 7:16 PM EDT - 6 weeks ago

GRAIL, Inc. (GRAL) Q1 2025 Earnings Call Transcript

GRAIL Reports First Quarter 2025 Financial Results

May 13, 2025, 4:01 PM EDT - 6 weeks ago

GRAIL Reports First Quarter 2025 Financial Results

GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test

May 12, 2025, 4:01 PM EDT - 6 weeks ago

GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test

GRAIL to Announce First Quarter 2025 Financial Results

Apr 29, 2025, 4:01 PM EDT - 2 months ago

GRAIL to Announce First Quarter 2025 Financial Results

GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting

Apr 22, 2025, 4:01 PM EDT - 2 months ago

GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting

This Cancer Test Could Become Routine—and a Big Seller, Says Analyst

Apr 21, 2025, 4:47 PM EDT - 2 months ago

This Cancer Test Could Become Routine—and a Big Seller, Says Analyst

GRAIL's Galleri Progresses While Back In Accumulation Levels

Apr 12, 2025, 9:32 AM EDT - 2 months ago

GRAIL's Galleri Progresses While Back In Accumulation Levels

How Does GRAIL Benefit From The Proposed MCED Legislation?

Apr 8, 2025, 9:49 AM EDT - 2 months ago

How Does GRAIL Benefit From The Proposed MCED Legislation?

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing

Feb 25, 2025, 9:00 AM EST - 4 months ago

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing

GRAIL to Present at TD Cowen 45th Annual Health Care Conference

Feb 21, 2025, 9:00 AM EST - 4 months ago

GRAIL to Present at TD Cowen 45th Annual Health Care Conference

GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 10:09 PM EST - 4 months ago

GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript

GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 20, 2025, 4:02 PM EST - 4 months ago

GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results

GRAIL to Announce Fourth Quarter 2024 Financial Results

Feb 12, 2025, 4:02 PM EST - 4 months ago

GRAIL to Announce Fourth Quarter 2024 Financial Results

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

Feb 12, 2025, 9:00 AM EST - 4 months ago

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

DGX

Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week

Jan 27, 2025, 12:05 AM EST - 5 months ago

Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week

Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20%

Jan 22, 2025, 1:01 PM EST - 5 months ago

Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20%

Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology

Jan 13, 2025, 6:49 PM EST - 5 months ago

Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 18, 2024, 4:01 PM EST - 6 months ago

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

World's biggest hedge fund flags the ‘holy grail' that may shield investors if U.S. stock rally crumbles

Dec 5, 2024, 5:46 AM EST - 7 months ago

World's biggest hedge fund flags the ‘holy grail' that may shield investors if U.S. stock rally crumbles

GRAIL to Participate in Upcoming Investor Conferences

Nov 19, 2024, 4:05 PM EST - 7 months ago

GRAIL to Participate in Upcoming Investor Conferences

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

Nov 18, 2024, 4:01 PM EST - 7 months ago

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

AZN

GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 4:18 AM EST - 8 months ago

GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript

GRAIL Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 4:06 PM EST - 8 months ago

GRAIL Reports Third Quarter 2024 Financial Results

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Nov 4, 2024, 4:01 PM EST - 8 months ago

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

GRAIL to Announce Third Quarter 2024 Financial Results

Oct 29, 2024, 4:01 PM EDT - 8 months ago

GRAIL to Announce Third Quarter 2024 Financial Results

GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference

Oct 23, 2024, 6:00 PM EDT - 8 months ago

GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference

GRAIL Appoints Sarah Krevans to Board of Directors

Oct 21, 2024, 4:01 PM EDT - 8 months ago

GRAIL Appoints Sarah Krevans to Board of Directors

Stock Picks From Seeking Alpha's September 2024 New Analysts

Oct 4, 2024, 8:00 AM EDT - 9 months ago

Stock Picks From Seeking Alpha's September 2024 New Analysts

AME CCL CRWD CUK DVN EGO EMR

Vieu cracks the “holy grail” of B2B sales with AI-powered business network; raises $11m as growth scales

Oct 3, 2024, 12:30 PM EDT - 9 months ago

Vieu cracks the “holy grail” of B2B sales with AI-powered business network; raises $11m as growth scales

GRAIL: Post-Spinoff, Illumina Maintains Control And Incentive To Support Success

Sep 24, 2024, 12:41 PM EDT - 9 months ago

GRAIL: Post-Spinoff, Illumina Maintains Control And Incentive To Support Success

ILMN

GRAIL's Potential Turnaround: Seeking FDA Approval For Galleri

Sep 9, 2024, 9:16 AM EDT - 10 months ago

GRAIL's Potential Turnaround: Seeking FDA Approval For Galleri

EU top court backs Illumina fight against EU probe into Grail deal

Sep 3, 2024, 3:50 AM EDT - 10 months ago

EU top court backs Illumina fight against EU probe into Grail deal

ILMN

GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)

Aug 30, 2024, 5:55 PM EDT - 10 months ago

GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology

Aug 29, 2024, 4:16 PM EDT - 10 months ago

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology

ILMN

GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 21, 2024, 4:01 PM EDT - 11 months ago

GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

GRAIL Inc. (GRAL) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 8:44 PM EDT - 11 months ago

GRAIL Inc. (GRAL) Q2 2024 Earnings Call Transcript

Grail to cut jobs, planned hires for 2024 by about 30%

Aug 13, 2024, 4:13 PM EDT - 11 months ago

Grail to cut jobs, planned hires for 2024 by about 30%

GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update

Aug 13, 2024, 4:01 PM EDT - 11 months ago

GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update

GRAIL to Announce Second Quarter 2024 Financial Results

Jul 31, 2024, 4:05 PM EDT - 11 months ago

GRAIL to Announce Second Quarter 2024 Financial Results

GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population

Jul 18, 2024, 9:00 AM EDT - 1 year ago

GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population

GRAIL Advances the Galleri® Registrational Clinical Trial Program

Jul 15, 2024, 3:01 AM EDT - 1 year ago

GRAIL Advances the Galleri® Registrational Clinical Trial Program

Undercovered Dozen: Telus Corporation, X-FAB Silicon Foundries, GRAIL, And More

Jun 28, 2024, 2:30 PM EDT - 1 year ago

Undercovered Dozen: Telus Corporation, X-FAB Silicon Foundries, GRAIL, And More

TU

Illumina: Marriage Made In Hell Is (Finally) Over - Assessing Impact Of GRAIL Spin-Out

Jun 28, 2024, 4:35 AM EDT - 1 year ago

Illumina: Marriage Made In Hell Is (Finally) Over - Assessing Impact Of GRAIL Spin-Out

ILMN

Illumina to take $1.47 bln goodwill impairment charge related to Grail in Q2

Jun 27, 2024, 5:26 PM EDT - 1 year ago

Illumina to take $1.47 bln goodwill impairment charge related to Grail in Q2

ILMN

healthcareguru
healthcareguru Jun. 28 at 2:27 AM
PSA: LOOKING FOR NEW GREAT HEALTHCARE IDEAS (where maybe we overlooked / missed an opportunity)! DM me if you want to pitch an idea. #teamguru 💵🐺💪 $XLV $TDOC $HIMS $TEM $GRAL
0 · Reply
dubale
dubale Jun. 27 at 8:42 PM
$GRAL Anyone catching the volume spike last 15 minutes? Around 5 millions. Any idea?
2 · Reply
SHELBY_TRADING
SHELBY_TRADING Jun. 27 at 7:58 PM
$GRAL Fishes try to fud here. 😂😂😂 100$+ thats the plan !
0 · Reply
dubale
dubale Jun. 27 at 5:20 PM
$GRAL I don’t understand people who is selling at this level. If you short term trader you’re okay with that. But if you long term keep buying. It’s not double top trend. Stock will continue rise next week. Be smart!
1 · Reply
Bazzzigar
Bazzzigar Jun. 27 at 4:35 PM
$GRAL offering?
1 · Reply
dubale
dubale Jun. 27 at 3:40 PM
$GRAL Good time to take profit. Always buy on a down day!
0 · Reply
dubale
dubale Jun. 27 at 3:24 PM
$GRAL Perfecto!
1 · Reply
dubale
dubale Jun. 27 at 2:01 PM
$GRAL Remember $49+ level is resistance which could turn to support. Highly important level!
1 · Reply
Titoscoisas
Titoscoisas Jun. 26 at 11:50 PM
$GRAL
0 · Reply
rxptgh
rxptgh Jun. 26 at 11:10 PM
$GRAL a beast
0 · Reply
vainey
vainey Jun. 26 at 8:46 PM
$GRAL lfg
0 · Reply
Monkey_Banana_Genius
Monkey_Banana_Genius Jun. 26 at 7:52 PM
$QS $GRAL $HIMS $SG WHAT A FOOKING DAY, WEEK, YEAR, DECADE!!!!
3 · Reply
SHELBY_TRADING
SHELBY_TRADING Jun. 26 at 7:16 PM
$GRAL listen to me. We will Break 52wk High by End of July. 🫡
0 · Reply
dubale
dubale Jun. 26 at 6:56 PM
$GRAL Just a reminder need to break $49+ major resistance.
0 · Reply
Bazzzigar
Bazzzigar Jun. 26 at 5:18 PM
$GRAL HIMS
0 · Reply
RemitTekram
RemitTekram Jun. 26 at 5:05 PM
$GRAL
0 · Reply
dubale
dubale Jun. 26 at 3:45 PM
$GRAL $49+ is a major resistance.
1 · Reply
AnniyanS
AnniyanS Jun. 26 at 2:23 PM
$GRAL Over $50 soon.
0 · Reply
strategicmind
strategicmind Jun. 26 at 2:12 PM
$GRAL very bullish on this name. Early cancer detection and screening should be MANDATORY! People don’t see signs before it’s too late.
0 · Reply
JFDI
JFDI Jun. 26 at 2:06 PM
$GRAL
0 · Reply
healthcareguru
healthcareguru Jun. 26 at 12:24 PM
$GRAL Morgan Stanley just shat all over this overvalued turd… 😂👎
1 · Reply
dubale
dubale Jun. 26 at 11:22 AM
$GRAL Morgan Stanley upgrade. Target price $38
0 · Reply